LeonaBio Financials - Benzinga

LeonaBio Inc

LONANASDAQ

Trade with Public

Trade with Public

$7.73

0.0450.59%

At close: Aug 24, 5:00 PM EST

$8.15

0.425.43%

After Hours: Aug 17, 7:35 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

LeonaBio Financials

LeonaBio (LONA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
LeonaBio Q2 EPS $(0.80) Beats $(1.36) Estimate

LeonaBio (NASDAQ:LONA) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.36) by 41.18 percent. This is a 55.56 percent increase over losses of $(1.80) per share from the

Benzinga Newsdesk

PRO
LeonaBio Q1 EPS $(1.73) Beats $(2.50) Estimate

LeonaBio (NASDAQ:LONA) reported quarterly losses of $(1.73) per share which beat the analyst consensus estimate of $(2.50) by 30.8 percent. This is a 26.07 percent increase over losses of $(2.34) per share from the same

Benzinga Newsdesk

PRO
LeonaBio Q4 EPS $(2.77) Misses $(0.84) Estimate

LeonaBio (NASDAQ:LONA) reported quarterly losses of $(2.77) per share which missed the analyst consensus estimate of $(0.84) by 229.76 percent. This is a 28.97 percent increase over losses of $(3.90) per share from the

Benzinga Newsdesk